IRRAS AB, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, announced the issuance of United States Patent No. 10,293,105 for its “Fluid Exchange Catheter System” technology upon which the company’s lead IRRAflow technology is based.
August 1, 2019
· 2 min read